Literature DB >> 12567253

[Blistering autoimmune diseases of childhood].

M Goebeler1, D Zillikens.   

Abstract

Autoimmune blistering skin diseases are exceedingly rare in children. In most cases, they are characterized by circulating autoantibodies directed against adhesion structures of the skin which subsequently induce blistering at the dermoepidermal junction or intraepidermally. The most frequent paediatric immunobullous disease is linear IgA dermatosis; all others such as pemphigoid, epidermolysis bullosa acquisita, dermatitis herpetiformis and pemphigus are less common than in adults. In children, mucous membranes are involved more frequently. Recent advances in the identification of the autoantigens have improved diagnostic approach and therapeutic management of blistering diseases. In most cases, treatment requires systemic immunosuppression. With respect to the chronic course of the diseases and potential complications of treatment, cooperation between dermatologists and paediatricians seems advisable.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12567253     DOI: 10.1007/s00105-002-0466-1

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  27 in total

1.  Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus.

Authors:  L Borradori; T Lombardi; J Samson; C Girardet; J H Saurat; A Hügli
Journal:  Arch Dermatol       Date:  2001-03

Review 2.  Treatment of subepidermal immunobullous diseases.

Authors:  F Wojnarowska; G Kirtschig; N Khumalo
Journal:  Clin Dermatol       Date:  2001 Nov-Dec       Impact factor: 3.541

3.  Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap.

Authors:  F Wojnarowska; R A Marsden; B Bhogal; M M Black
Journal:  J Am Acad Dermatol       Date:  1988-11       Impact factor: 11.527

4.  IgA linear dermatosis of childhood (chronic bullous disease of childhood).

Authors:  T P Chorzelski; S Jablonska
Journal:  Br J Dermatol       Date:  1979-11       Impact factor: 9.302

Review 5.  Current concepts of celiac disease pathogenesis.

Authors:  D Schuppan
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

6.  Misdiagnosis, treatments, and outcomes in the immunobullous diseases in children.

Authors:  W L Weston; J G Morelli; J C Huff
Journal:  Pediatr Dermatol       Date:  1997 Jul-Aug       Impact factor: 1.588

Review 7.  Childhood, neonatal, and stillborn pemphigus vulgaris.

Authors:  B Bjarnason; E Flosadóttir
Journal:  Int J Dermatol       Date:  1999-09       Impact factor: 2.736

8.  Childhood epidermolysis bullosa acquisita: a novel variant with reactivity to all three structural domains of type VII collagen.

Authors:  E Schmidt; B Höpfner; M Chen; C Kuhn; L Weber; E-B Bröcker; L Bruckner-Tuderman; D Zillikens
Journal:  Br J Dermatol       Date:  2002-09       Impact factor: 9.302

9.  Neonatal pemphigus vulgaris with extensive mucocutaneous lesions from a mother with oral pemphigus vulgaris.

Authors:  A Campo-Voegeli; F Muñiz; J M Mascaró; F García; M Casals; J L Arimany; M Amagai; A Camps
Journal:  Br J Dermatol       Date:  2002-10       Impact factor: 9.302

10.  Juvenile pemphigus foliaceus.

Authors:  M Mehravaran; M Morvay; K Molnár; J Oláh; I Korom; S Husz; A Dobozy
Journal:  Br J Dermatol       Date:  1998-09       Impact factor: 9.302

View more
  3 in total

1.  [Differential diagnosis of oral mucosal erosions and ulcers in children].

Authors:  S Benoit; H Hamm
Journal:  Hautarzt       Date:  2015-04       Impact factor: 0.751

Review 2.  [Bullous autoimmune disorders in children].

Authors:  M Sárdy; M Kasperkiewicz
Journal:  Hautarzt       Date:  2013-06       Impact factor: 0.751

3.  [Pemphigus diseases in children and adolescents].

Authors:  M Meurer
Journal:  Hautarzt       Date:  2009-03       Impact factor: 0.751

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.